By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 23andMe today said that it has closed on its Series C financing, raising more than $22 million.

New investor Johnson & Johnson Development Corp. participated in the round, which also included New Enterprise Associates and Google Ventures, the Mountain View, Calif.-based personal genetics testing firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.